Clinical Trials Directory

Trials / Unknown

UnknownNCT04640350

Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Through the parameters of liver stiffness and spleen stiffness obtained by combi-elastography technique, summarize and analyze the warning index of esophagogastric variceal bleeding in patients with cirrhosis, so as to provide a new and valuable technique for clinical diagnosis.

Detailed description

Firstly,the combi-elastography technique developed by HITACHI uses the method of multi-index and multi-parameter to evaluate the liver stiffness and spleen stiffness comprehensively. And then,this prospective study is designed to follow up patients with cirrhosis for a period of 12 months, summarize and analyze the warning index of bleeding in patients with cirrhosis,so as to provide a new and valuable technique for clinical diagnosis.

Conditions

Timeline

Start date
2020-12-31
Primary completion
2022-12-31
Completion
2023-05-31
First posted
2020-11-23
Last updated
2021-01-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04640350. Inclusion in this directory is not an endorsement.